| 000 | 01764 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518042204.0 | ||
| 264 | 0 | _c20200901 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2019.05.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHopkins, Brian T | |
| 245 | 0 | 0 |
_aOptimization of novel reversible Bruton's tyrosine kinase inhibitors identified using Tethering-fragment-based screens. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _c07 2019 |
||
| 300 |
_a2905-2913 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAgammaglobulinaemia Tyrosine Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 700 | 1 | _aBame, Eris | |
| 700 | 1 | _aBell, Noah | |
| 700 | 1 | _aBohnert, Tonika | |
| 700 | 1 | _aBowden-Verhoek, Jon K | |
| 700 | 1 | _aBui, Minna | |
| 700 | 1 | _aCancilla, Mark T | |
| 700 | 1 | _aConlon, Patrick | |
| 700 | 1 | _aCullen, Patrick | |
| 700 | 1 | _aErlanson, Daniel A | |
| 700 | 1 | _aFan, Junfa | |
| 700 | 1 | _aFuchs-Knotts, Tarra | |
| 700 | 1 | _aHansen, Stig | |
| 700 | 1 | _aHeumann, Stacey | |
| 700 | 1 | _aJenkins, Tracy J | |
| 700 | 1 | _aMarcotte, Douglas | |
| 700 | 1 | _aMcDowell, Bob | |
| 700 | 1 | _aMertsching, Elisabeth | |
| 700 | 1 | _aNegrou, Ella | |
| 700 | 1 | _aOtipoby, Kevin L | |
| 700 | 1 | _aPoreci, Urjana | |
| 700 | 1 | _aRomanowski, Michael J | |
| 700 | 1 | _aScott, Daniel | |
| 700 | 1 | _aSilvian, Laura | |
| 700 | 1 | _aYang, Wenjin | |
| 700 | 1 | _aZhong, Min | |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 27 _gno. 13 _gp. 2905-2913 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2019.05.021 _zAvailable from publisher's website |
| 999 |
_c29739046 _d29739046 |
||